Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

US Vivitrol Promotional Report 2016/17 - Research and Markets

Research and Markets
Posted on: 07 Sep 17

The "Vivitrol 2016 U.S. Promotional Report" report has been added to Research and Markets' offering.

The 5 Key Questions Addressed by this Report:

  • How many physicians were reached by Vivitrol through personal promotion in 2016 and how does this compare to its peer set in the Opioid Abuse markets?
  • What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend on each type of activity?
  • How does Alkermes's depth of coverage vary within key specialties (e.g., Psychiatry, Family Medicine, Internal Medicine, and Addiction Medicine) and how does this compare to its peers and the overall set of rep-accessible physicians?
  • How often are physicians receiving paid meals for Vivitrol throughout the year (e.g., monthly, quarterly, annually)?
  • Who were the most detailed prescribers and top paid speakers for Vivitrol in 2016?

Data Sources and Methodology:

  • We leverage company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. Currently, 42 months of longitudinal data is available - covering payments to more than 900,000 U.S. healthcare professionals.
  • Over 4,300 paid interactions across 2,400 physicians made on behalf of Vivitrol were carefully examined to support our analysis. In addition, interaction data from 3 peer products (e.g. Bunavail, Probuphine, and Zubsolv ) was leveraged to provide benchmarking and market insights.

For more information about this report visit https://www.researchandmarkets.com/research/78zt4b/vivitrol_2016_u_s

View source version on businesswire.com: http://www.businesswire.com/news/home/20170907006276/en/

Business Wire
www.businesswire.com

Last updated on: 07/09/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.